Differential transcriptional effects of PTH and estrogen during anabolic bone formation.

Item

http://www.wikidata.org/entity/Q45062626

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Differential transcriptional effects of PTH and estrogen during anabolic bone formation.

@en

Differential transcriptional effects of PTH and estrogen during anabolic bone formation.

@nl

type

Item

label

Differential transcriptional effects of PTH and estrogen during anabolic bone formation.

@en

Differential transcriptional effects of PTH and estrogen during anabolic bone formation.

@nl

prefLabel

Differential transcriptional effects of PTH and estrogen during anabolic bone formation.

@en

Differential transcriptional effects of PTH and estrogen during anabolic bone formation.

@nl

P1476

Differential transcriptional effects of PTH and estrogen during anabolic bone formation

@en

P2093

D Zurakowski

http://www.w3.org/2001/XMLSchema#string

D von Stechow

http://www.w3.org/2001/XMLSchema#string

Joseph M Alexander

http://www.w3.org/2001/XMLSchema#string

M Chorev

http://www.w3.org/2001/XMLSchema#string

P2860

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass

Estrogen receptor-alpha is developmentally regulated during osteoblast differentiation and contributes to selective responsiveness of gene expression

Estrogen activates cyclin-dependent kinases 4 and 6 through induction of cyclin D in rat primary osteoblasts

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients.

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis.

Evidence for a regulatory role of inducible cAMP early repressor in protein kinase a-mediated enhancement of vitamin D receptor expression and modulation of hormone action.

Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells.

Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis.

P304

476-490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCB.20174

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15372627

http://www.w3.org/2001/XMLSchema#string